Skip to main content
Premium Trial:

Request an Annual Quote

Prodesse Licenses Multiplexing, Molecular Detection Patents from Abbott

NEW YORK (GenomeWeb News) – Prodesse has licensed two patents from Abbott that cover multiplexing and molecular detection technologies, the Wisconsin-based company said yesterday.

Under the agreement, Prodesse acquired non-exclusive sub-licenses for US Patent No. 5,582,989, and US Patent No. 5,851,767.

The '989 "Caskey" patent, assigned to Baylor College of Medicine, covers molecular multiplexing and the '767 "Stanbridge" patent, assigned to the University of California, covers molecular detection of prokaryotic organisms, mostly bacteria.

Baylor and UC exclusively licensed these patents to Abbott, with the right to grant sublicenses.

Financial terms of the agreement were not released.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.